A recent study of patients with kidney failure receiving outpatient hemodialysis1,2 found similar effectiveness between nonpharmacological and pharmacological treatments for depression.
Depression is common among patients with kidney failure and is associated with poor outcomes including higher risk of kidney function decline, hospitalization, and death. In the United States, the Centers for Medicare & Medicaid Services (CMS) requires dialysis facilities to screen patients for depression. Positive screenings require kidney care teams to create a follow-up plan for further assessment and treatment.3
Read the full article from Patient-Centered Outcomes Research Institute.